Eaton Vance Management’s Acceleron Pharma XLRN Stock Holding History

Eaton Vance Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-133	Closed	–	–	2925
2021 Q3	$0	Buy	133 +116	+682%	+$15.2K	﹤0.01%	2878
2021 Q2	$2K	Sell	17 -617	-97%	-$77.8K	﹤0.01%	2742
2021 Q1	$86K	Buy	+634	New	+$81.9K	﹤0.01%	1645

Eaton Vance Management's XLRN Position: Q4 2021 in Review

Eaton Vance Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 133 shares.

Eaton Vance Management first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $86K in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Eaton Vance Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Eaton Vance Management sold 133 Acceleron Pharma shares in Q4 2021.
Eaton Vance Management first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
Eaton Vance Management's Acceleron Pharma position peaked at $86K in Q1 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Eaton Vance Management's 13F filing for Q4 2021, filed 14 Feb 2022.